RHYTHM PHARMACEUTICALS, INC. - COM (RYTM)

Historical Portfolio Holders from Q4 2017 to Q3 2024

All holders as of June 30, 2024
Q2 2024
Type / Class
Equity / COM
Shares, excl. options Q2 2024
69.3M
Holdings value Q2 2024
$2.85B
Value change Q2 2024
+$55.5M
Grand Portfolio weight change Q2 2024
+0%
Number of holders
163
Number of buys Q2 2024
86
Number of sells Q2 2024
-75
Average buys Q2 2024 %
+0.001%
Average sells Q2 2024 %
-0.001%
Reported Shares, Excluding Options vs Price
Reported Value, Excluding Options
Total Investors
Period Shares, Excl. Options Value, Excl. Options Change Price Investors
2024 Q3 28.8K $1.51M -$1.2M $52.39 3
2024 Q2 69.3M $2.85B +$55.5M $41.06 165
2024 Q1 68M $2.94B +$53.1M $43.33 169
2023 Q4 66.7M $3.07B -$42M $45.97 169
2023 Q3 68.1M $1.56B +$58.5M $22.93 145
2023 Q2 66.2M $1.09B +$94.1M $16.49 116
2023 Q1 60.3M $1.08B -$49.1M $17.84 126
2022 Q4 62.3M $1.81B +$85.6M $29.12 116
2022 Q3 59.5M $1.45B +$425M $24.50 99
2022 Q2 45.9M $191M -$18.8M $4.15 81
2022 Q1 48.8M $562M +$4.65M $11.52 104
2021 Q4 48.4M $483M -$647K $9.98 94
2021 Q3 47.9M $626M +$2.35M $13.06 93
2021 Q2 42.6M $835M -$3.43M $19.58 101
2021 Q1 47.6M $1.01B +$147M $21.27 120
2020 Q4 40.5M $1.2B +$39.5M $29.73 116
2020 Q3 39.2M $851M -$43.7M $21.67 115
2020 Q2 41.2M $920M +$12M $22.30 89
2020 Q1 40.8M $621M -$34.2M $15.22 80
2019 Q4 42.4M $973M +$189M $22.96 89
2019 Q3 34.3M $741M +$64.8M $21.59 84
2019 Q2 31.3M $688M +$9.1M $22.00 83
2019 Q1 30.9M $846M -$21.9M $27.41 85
2018 Q4 31.7M $851M +$12.8M $26.88 73
2018 Q3 31.1M $908M +$2.06M $29.17 77
2018 Q2 31M $970M +$216M $31.26 84
2018 Q1 24.4M $406M -$5.86M $19.90 54
2017 Q4 21.6M $628M +$507M $29.06 65